Drug Shortage Report for GEMCITABINE INJECTION
| Report ID | 89859 |
| Drug Identification Number | 02412292 |
| Brand name | GEMCITABINE INJECTION |
| Common or Proper name | GEMCITABIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | GEMCITABINE |
| Strength(s) | 40MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 5 Vials |
| ATC code | L01BC |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2019-06-24 |
| Estimated end date | 2019-07-29 |
| Actual end date | 2019-08-06 |
| Shortage status | Resolved |
| Updated date | 2019-09-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-09-25 | French | Compare |
| v3 | 2019-09-25 | English | Compare |
| v2 | 2019-07-24 | French | Compare |
| v1 | 2019-07-24 | English | Compare |
Showing 1 to 4 of 4